Clinical trials
Hemorrhagic Shock clinical trials
Below are recruiting hemorrhagic shock clinical trials, each written for real people, not researchers. We’re tracking 11 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT02880163Recruiting
Test foam used to stop dangerous internal abdominal bleeding
This trial tests whether an expandable foam can quickly help slow or control life-threatening bleeding inside the belly. It is designed for emergency situations where surgery to stop the bleeding will happen soon.
Birmingham, AlabamaAges 15 years+ - NCT06070350RecruitingPhase 3
Massive transfusion for life-threatening bleeding in children
This study tests whether adding the drug tranexamic acid (TXA) to a massive blood transfusion helps control life-threatening bleeding in children who are severely injured. It compares two groups: one gets TXA and the other gets a placebo (a dummy drug with no active ingredient).
Tucson, ArizonaAges Up to 17 years - NCT04615065Recruiting
Biobank study collecting emergency data for very sick patients
This study collects health and sometimes blood sample information from people arriving at the emergency department with high-risk or serious conditions. The goal is to build a large emergency “biobank” to help researchers better understand and improve urgent care.
GroningenAges 18 years+ - NCT05634109RecruitingPhase 3
Whole blood to treat adults with severe bleeding trauma
This trial compares giving whole blood versus standard care in adults with severe trauma and dangerous blood loss (hemorrhagic shock). The goal is to see if whole blood helps stabilize patients faster and improves outcomes after major bleeding.
Cali, Valle del Cauca DepartmentAges 18 years+ - NCT05638581RecruitingPhase 3
Compare low-titer type O whole blood for trauma bleeding
This study tests whether giving low-titer type O whole blood (or related blood products) works better for treating serious bleeding after a traumatic injury. It’s for adults who start blood transfusions right away under a massive bleeding plan.
Birmingham, AlabamaAges 15 years+ - NCT06531642RecruitingPhase 2/Phase 3
Early acid-reducing drug for kidney injury after severe bleeding
This study tests whether giving a common acid-reducing medication (a proton pump inhibitor, or PPI) early after severe bleeding from trauma can help protect the kidneys from injury. It compares this early treatment to usual care.
Houston, TexasAges 18 years+ - NCT06670248Recruiting
Study of blood vessel health during burn surgery
This trial looks at how a protective layer inside your blood vessels (called the glycocalyx) responds during surgery to remove burned skin. The goal is to improve care for people with major burns.
Barcelona, SpainAges 18 years+ - NCT06977659Enrolling by invitationPhase 1/Phase 2
Early norepinephrine for trauma patients with heavy bleeding
This trial tests whether giving norepinephrine early helps adults with severe bleeding from injury. It is for patients who have lost a lot of blood or show signs of shock.
BangkokAges 18–65 - NCT07207629Enrolling by invitation
Heart ultrasound study in healthy blood donors
This study uses a heart ultrasound (echocardiography) to see how the heart changes when healthy volunteers donate blood. If you're a healthy adult who can donate blood, you may help researchers understand more about blood donation's effect on the heart.
Nîmes, OccitanieAges 18–40 - NCT06725602Enrolling by invitation
Prehospital tourniquet study for arms and legs
This trial tests different tourniquet models used in emergencies to stop blood flow in arms and legs. It may help find the best way to control bleeding before reaching a hospital.
Ribeirão Preto, São PauloAges 18–60 - NCT07273643Recruiting
Studying tiny particles in cord blood of very premature babies
This study looks at microscopic particles called extracellular vesicles in the umbilical cord blood of babies born before 28 weeks. Researchers want to see if these particles can help predict severe health problems or death, and eventually improve care for extremely premature newborns.
MontpellierAges birth–3 months
Hear when a new Hemorrhagic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for hemorrhagic shock?
- Yes. Clin2 currently lists 11 recruiting hemorrhagic shock studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a hemorrhagic shock trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a hemorrhagic shock trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.